08:00 , Nov 9, 2015 |  BC Week In Review  |  Company News

Cevec, CellGenix deal

Cevec granted CellGenix non-exclusive, worldwide rights to develop and commercialize cytokines and growth and differentiation factors derived from Cevec’s CAPGo platform for ex vivo cell culture therapy applications. CAPGo uses glyco-optimized human cell lines to...
07:00 , Jun 22, 2009 |  BC Week In Review  |  Clinical News

IdioVax regulatory update

EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for CellGenix's IdioVax to treat diffuse large B cell lymphoma (DLBCL). IdioVax, a recombinant vaccine containing a histidine-tagged idiotype...
07:00 , Oct 5, 1998 |  BioCentury  |  Politics, Policy & Law

German biotech crosses party lines

German biotech crosses party lines StateGoverning parties # cos Leading lights Baden Wurttemberg Christian Democrat Union 37 LION bioscience, BASF-Lynx, BIG Biotech, CellGenix, Metabion N Rhine Westphalia Social Democrat/Green 28 Qiagen, Artemis, CardioGene, Greentech, NewLab...